MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent
- PMID: 9039617
- DOI: 10.1002/jmri.1880070132
MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent
Abstract
The purpose of the study was to investigate the use of a dextran-coated ultrasmall superparamagnetic iron oxide (USPIO) as a blood pool contrast agent for thoracic and abdominal MR angiography. Abdominal and thoracic MR angiography was performed in six healthy volunteers using two-dimensional and three-dimensional spoiled gradient echo (SPGR) sequences before and after intravenous administration of USPIO. Doses ranged from 1.1 to 2.6 mg Fe/kg. Flip angle was varied from 20 to 60 degrees. Subjective image quality, analysis of signal-to-noise ratio (SNR), and blood T1 relaxation times were measured. USPIO significantly lowered the T1 of blood (from 1,210 ms precontrast to 159 ms postcontrast at a dose of 2.6 mg Fe/kg) (P < .01). Image quality on coronal fast three-dimensional breath-hold SPGR images of the abdomen increased with increasing dose and was maximum at the highest dose, producing an aortic SNR of 9.6 compared to 1.8 precontrast. Axial two-dimensional time-of-flight (TOF) aortic SNR was reduced significantly from 13 on precontrast to 6 on the postcontrast images at the highest dose (P < .05) due to T2* shortening effects. There was little flip angle dependence on image quality. Due to the T1 shortening effect and long intravascular half-life, USPIO improved visualization of vascular anatomy using three-dimensional fast SPGR imaging. The echo time must be minimized to minimize signal loss from T2* shortening effects. The blood pool distribution of USPIO is useful for equilibrium-phase MR angiography.
Similar articles
-
Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries.AJR Am J Roentgenol. 1996 Apr;166(4):971-81. doi: 10.2214/ajr.166.4.8610584. AJR Am J Roentgenol. 1996. PMID: 8610584
-
Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer.AJR Am J Roentgenol. 1998 Jul;171(1):107-13. doi: 10.2214/ajr.171.1.9648772. AJR Am J Roentgenol. 1998. PMID: 9648772
-
First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.NMR Biomed. 2004 Nov;17(7):500-6. doi: 10.1002/nbm.906. NMR Biomed. 2004. PMID: 15523717 Clinical Trial.
-
Dynamic four-dimensional MR angiography of the chest and abdomen.Magn Reson Imaging Clin N Am. 2009 Feb;17(1):77-90. doi: 10.1016/j.mric.2008.12.001. Magn Reson Imaging Clin N Am. 2009. PMID: 19364601 Review.
-
The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts.Abdom Radiol (NY). 2024 Aug;49(8):2858-2872. doi: 10.1007/s00261-024-04268-x. Epub 2024 Apr 1. Abdom Radiol (NY). 2024. PMID: 38561553 Review.
Cited by
-
Cerebral blood volume MRI with intravascular superparamagnetic iron oxide nanoparticles.NMR Biomed. 2013 Aug;26(8):949-62. doi: 10.1002/nbm.2885. Epub 2012 Dec 4. NMR Biomed. 2013. PMID: 23208650 Free PMC article. Review.
-
Magnetic resonance molecular imaging with nanoparticles.J Nucl Cardiol. 2004 Nov-Dec;11(6):733-43. doi: 10.1016/j.nuclcard.2004.09.002. J Nucl Cardiol. 2004. PMID: 15592197 Review.
-
Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches.Theranostics. 2018 Sep 9;8(17):4710-4732. doi: 10.7150/thno.26284. eCollection 2018. Theranostics. 2018. PMID: 30279733 Free PMC article. Review.
-
Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.AJNR Am J Neuroradiol. 2002 Apr;23(4):510-9. AJNR Am J Neuroradiol. 2002. PMID: 11950637 Free PMC article.
-
High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.Pediatr Radiol. 2022 Mar;52(3):501-512. doi: 10.1007/s00247-021-05225-2. Epub 2021 Dec 22. Pediatr Radiol. 2022. PMID: 34936018 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources